These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11315954)

  • 41. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
    Béliveau R; Gingras D; Kruger EA; Lamy S; Sirois P; Simard B; Sirois MG; Tranqui L; Baffert F; Beaulieu E; Dimitriadou V; Pépin MC; Courjal F; Ricard I; Poyet P; Falardeau P; Figg WD; Dupont E
    Clin Cancer Res; 2002 Apr; 8(4):1242-50. PubMed ID: 11948139
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of cyclo-oxygenase 1 and 2, prostaglandin E synthase and transforming growth factor beta1, and their relationship with vascular endothelial growth factors A and C, in primary adenocarcinoma of the small intestine.
    von Rahden BH; Brücher BL; Langner C; Siewert JR; Stein HJ; Sarbia M
    Br J Surg; 2006 Nov; 93(11):1424-32. PubMed ID: 17022010
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
    Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
    Eur Cytokine Netw; 2001; 12(3):445-52. PubMed ID: 11566625
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Influence of Qianlie Antong tablets on expresstion of VEGF and bFGF in protatic tissues of BHP rats].
    Xu B
    Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2381-4. PubMed ID: 19157134
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in serum and tissue zinc levels in sex hormone-induced prostatic carcinogenesis in the noble rat.
    Wong YC; Wang YZ; Lee JS; Tam NN; Lee D
    Tumour Biol; 2000; 21(6):328-36. PubMed ID: 11006573
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential effects of diethylstilbestrol and estradiol-17 beta in combination with testosterone on rat prostate lobes.
    Ofner P; Bosland MC; Vena RL
    Toxicol Appl Pharmacol; 1992 Feb; 112(2):300-9. PubMed ID: 1539166
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration.
    Noble RL
    Cancer Res; 1977 Jun; 37(6):1929-33. PubMed ID: 858144
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunohistochemical localization of growth factors and their receptors in uterine leiomyomas and matched myometrium.
    Dixon D; He H; Haseman JK
    Environ Health Perspect; 2000 Oct; 108 Suppl 5():795-802. PubMed ID: 11035985
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beta-adrenergic receptor blockade and prostate peptide growth factor expression in the rat.
    Mitropoulos D; Kyroudi-Voulgari A; Stratigea F; Perea D; Boudoulas H; Karayannacos P
    Immunopharmacol Immunotoxicol; 2010 Mar; 32(1):105-9. PubMed ID: 19778180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The aging ACI/Seg versus Copenhagen male rat as a model system for the study of prostatic carcinogenesis.
    Isaacs JT
    Cancer Res; 1984 Dec; 44(12 Pt 1):5785-96. PubMed ID: 6498839
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sex hormones induce direct epithelial and inflammation-mediated oxidative/nitrosative stress that favors prostatic carcinogenesis in the noble rat.
    Tam NN; Leav I; Ho SM
    Am J Pathol; 2007 Oct; 171(4):1334-41. PubMed ID: 17717140
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Production of autochthonous prostate cancer in Lobund-Wistar rats by treatments with N-nitroso-N-methylurea and testosterone.
    Pollard M; Luckert PH
    J Natl Cancer Inst; 1986 Aug; 77(2):583-7. PubMed ID: 3461217
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Nb rat: prostatic adenocarcinoma model.
    Drago JR; Ikeda RM; Maurer RE; Goldman LB; Tesluk H
    Invest Urol; 1979 Mar; 16(5):353-9. PubMed ID: 429131
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Suppression of testosterone and estradiol-17beta-induced dysplasia in the dorsolateral prostate of Noble rats by bromocriptine.
    Lane KE; Leav I; Ziar J; Bridges RS; Rand WM; Ho SM
    Carcinogenesis; 1997 Aug; 18(8):1505-10. PubMed ID: 9276623
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prostate adenocarcinoma in rats: induction by 3,2'-dimethyl-4-aminobiphenyl.
    Katayama S; Fiala E; Reddy BS; Rivenson A; Silverman J; Williams GM; Weisburger JH
    J Natl Cancer Inst; 1982 May; 68(5):867-73. PubMed ID: 6951094
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of a DNA adduct detectable by 32P-postlabeling in the dorsolateral prostate of NBL/Cr rats treated with estradiol-17 beta and testosterone.
    Han X; Liehr JG; Bosland MC
    Carcinogenesis; 1995 Apr; 16(4):951-4. PubMed ID: 7728979
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prostate carcinoma of the Nb rat in relation to hormones.
    Noble RL
    Int Rev Exp Pathol; 1982; 23():113-59. PubMed ID: 7045013
    [No Abstract]   [Full Text] [Related]  

  • 58. Quantitative determination of prostatic epithelial and stromal hyperplasia by a new technique. Biomorphometrics.
    DeKlerk DP; Coffey DS
    Invest Urol; 1978 Nov; 16(3):240-5. PubMed ID: 361633
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A new proposed rodent model of chemically induced prostate carcinogenesis: distinct time-course prostate cancer progression in the dorsolateral and ventral lobes.
    Gonçalves BF; de Campos SG; Zanetoni C; Scarano WR; Falleiros LR; Amorim RL; Góes RM; Taboga SR
    Prostate; 2013 Aug; 73(11):1202-13. PubMed ID: 23620436
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Growth factors and benign prostatic hyperplasia].
    Torrubia Romero FJ; Cruz Navarro N; Pascual del Pobil JL
    Rev Clin Esp; 1999 Apr; 199 Suppl 2():19-23. PubMed ID: 10887542
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.